Wang, Y., Li, Y., Zhang, L., Liu, R., Wu, W., Li, Y., . . . Investigators, S. Rationale and design of SCOPE trial: A prospective, multicentre, open-label, randomised controlled trial to evaluate the overall efficacy and safety of a short-term anticoagulation strategy versus conventional single antiplatelet therapy in patients with severe aortic stenosis without indications for anticoagulation or dual antiplatelet therapy post-transcatheter aortic valve replacement. BMJ Publishing Group.
Chicago Style (17th ed.) CitationWang, Yang, et al. Rationale and Design of SCOPE Trial: A Prospective, Multicentre, Open-label, Randomised Controlled Trial to Evaluate the Overall Efficacy and Safety of a Short-term Anticoagulation Strategy Versus Conventional Single Antiplatelet Therapy in Patients with Severe Aortic Stenosis Without Indications for Anticoagulation or Dual Antiplatelet Therapy Post-transcatheter Aortic Valve Replacement. BMJ Publishing Group.
MLA (9th ed.) CitationWang, Yang, et al. Rationale and Design of SCOPE Trial: A Prospective, Multicentre, Open-label, Randomised Controlled Trial to Evaluate the Overall Efficacy and Safety of a Short-term Anticoagulation Strategy Versus Conventional Single Antiplatelet Therapy in Patients with Severe Aortic Stenosis Without Indications for Anticoagulation or Dual Antiplatelet Therapy Post-transcatheter Aortic Valve Replacement. BMJ Publishing Group.